Skip to main content
. 2012 May;81(5):729–738. doi: 10.1124/mol.111.077339

Fig. 4.

Fig. 4.

Effects of TM5 serine mutations on potencies of catechol agonists. ΔpEC50 values of cAMP accumulation for the S198A, S199A, and S202A D1 receptor mutants relative to that for the wild-type receptor, were calculated from independent experiments performed in parallel. Data represent means and S.E.M for at least three matched experiments. The corresponding pEC50 values were all significantly different from the wild-type value (p < 0.05; one-way ANOVA with Dunnett's post-test). A, ΔpEC50 values at each mutant relative to the wild-type value, for the cyclohexyl-substituted isochroman (□), chroman (▩), and carbocyclic (■). *, p < 0.05; **, p < 0.01 significantly different from cyclohexyl chroman (one-way ANOVA with Dunnett's post-test). B, ΔpEC50 values at each mutant relative to the wild-type value for dopamine, apomorphine, and DHX. C, ΔpEC50 values at each mutant relative to the wild-type value for three phenylbenzazepine ligands.